Affordable Care Act
- Report
Testimony on Growth in the 340B Drug Pricing Program and Its Implications for the Federal Budget
Aditi Sen, Chief of CBO's Health Policy Studies Unit, testifies before the Senate Committee on Health, Education, Labor, and Pensions.
- Report
The Estimated Effects of Enacting Selected Health Coverage Policies on the Federal Budget and on the Number of People With Health Insurance
CBO estimates that permanently extending the expanded premium tax credit, nullifying a marketplace final rule, and repealing policies in the 2025 reconciliation act would increase deficits and the number of people with health insurance.
- Report
Growth in the 340B Drug Pricing Program
CBO examines drug purchases made through the 340B program in 2021, growth in such purchases from 2010 to 2021, and factors that contributed to that growth. CBO also assesses how the 340B program affects the federal budget.
- Report
Clarifications of Marketplace Coverage and Eligibility Under Public Law 119-21 (H.R. 1) and the 2025 Marketplace Integrity and Affordability Rule
CBO provides information about the effects of P.L. 119-21 (H.R. 1) on health insurance purchased through the ACA marketplaces and on improper receipt of subsidies, and the effects of a final rule published by HHS on marketplace subsidies.
- Blog Post
Upcoming Presentations by Staff of CBO’s Health Analysis Division
This summer, analysts in CBO's Health Analysis Division will present their work in three sessions at the 14th Annual Conference of the American Society of Health Economists (ASHEcon) in Nashville, Tennessee.
- Report
Federal Mandatory Spending for Means-Tested Programs and Tax Credits
CBO provides information concerning outlays for the government's major mandatory programs and tax credits that are primarily means-tested and provide assistance to people with relatively low income or few assets.
- Report
The Effects of Not Extending the Expanded Premium Tax Credits for the Number of Uninsured People and the Growth in Premiums
CBO provides estimates on how not extending the expanded premium tax credit will affect the number of people without health insurance and average gross benchmark premiums for plans purchased through the marketplaces.
- Report
Part 2 of Answers to Questions for the Record Following a Hearing on An Update to the Budget and Economic Outlook: 2024 to 2034
The Senate Committee on the Budget convened a hearing at which Phillip L. Swagel, CBO's Director, testified. This document provides CBO’s answers to 18 of the 29 questions submitted for the record.
- Report
The Effects of Permanently Extending the Expansion of the Premium Tax Credit and the Costs of that Credit for Deferred Action for Childhood Arrivals Recipients
CBO provides information about the effects on the budget and on health insurance coverage of permanently extending the expanded premium tax credit and about the costs of that credit for Deferred Action for Childhood Arrivals recipients.
- Blog Post
CBO Publishes New Projections Related to Health Insurance for 2024 to 2034
CBO published updated baseline projections of health insurance coverage and federal subsidies for it. The projections are described in an article published in the journal "Health Affairs" and a presentation on CBO’s website.